Literature DB >> 7431179

Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.

E Sarrazin, L Hendeles, M Weinberger, K Muir, S Riegelman.   

Abstract

In order to assess the clinical impact of dose-dependent kinetics for theophylline, the relationship between serum concentration and daily dosage among patients under the care of the University of Iowa Pediatric Allergy and Pulmonary Service was examined. Dosage was titrated clinically, with the final adjustment based on a serum theophylline measurement. Of 200 charts initially reviewed, 42 patients were found in whom at least two peak serum concentrations had been measured at different doses of the same theophylline preparation. In 30 (15% of initial 200) of these 42 patients, the percent change in serum concentration exceeded the percent change in dose by at least 50%. Subsequently, 300 additional charts were reviewed to identify a total of 26 patients with three steady-state serum concentrations at three different doses. Only five of these patients demonstrated a linear relationship between dose and serum concentration; the other 21 demonstrated disproportionate changes compatible with parallel first-order and dose-dependent kinetics. Thus, clinically important dose-dependent kinetics for theophylline occur in at least 15% of children, and theophylline dosage therefore must be adjusted in small increments in order to avoid disproportionately large changes in serum concentration with consequent risks of toxicity during continuous therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7431179     DOI: 10.1016/s0022-3476(80)80280-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  24 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 3.  A critique of dosing strategies for beta-2 adrenergic agents and theophylline.

Authors:  J W Jenne
Journal:  Lung       Date:  1981       Impact factor: 2.584

4.  Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.

Authors:  S Dadashzadeh; H Tajerzaden
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

5.  Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects.

Authors:  J Sato; H Nakata; E Owada; T Kikuta; M Umetsu; K Ito
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 7.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

8.  An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders.

Authors:  J McMichael; R Lieberman; H Doyle; J McCauley; J Fung; T E Starzl
Journal:  J Clin Pharmacol       Date:  1993-07       Impact factor: 3.126

9.  Pharmacokinetics of theophylline: a dose-range study.

Authors:  V Rovei; F Chanoine; M Strolin Benedetti
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

Review 10.  Role of extracorporeal drug removal in acute theophylline poisoning. A review.

Authors:  A Heath; K Knudsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.